NEW YORK, April 26 (GenomeWeb News) - Zeptosens said today that it will supply GlaxoSmithKline with custom-made protein microarrays.

 

Under the agreement, Zeptosens, located in Witterswil, Switzerland, will provide GSK with protein microarrays designed using GSK's analytes and binding reagents.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Two new Reproducibility Project: Cancer Biology studies have largely reproduced the original findings, ScienceInsider reports.

DNA fingerprinting could catch some sample mix-ups at pathology labs, the New York Times says.

A Maryland police department has turned to DNA phenotyping to develop a suspect sketch, WJLA reports.

In Cell this week: DNA methylation and T cell exhaustion, longevity in C. elegans, and more.